1. Szymanowicz, Oliwia, Drużdż, Artur, Słowikowski, Bartosz, Kozubski, Wojciech, Dorszewska, Jolanta. 2024. A Review of the CACNA Gene Family: Its Role in Neurological Disorders. In Diseases (Basel, Switzerland), 12, . doi:10.3390/diseases12050090. https://pubmed.ncbi.nlm.nih.gov/38785745/
2. Kim, Ji-Il, Miura, Yuki, Li, Min-Yin, Huguenard, John R, Pașca, Sergiu P. 2024. Human assembloids reveal the consequences of CACNA1G gene variants in the thalamocortical pathway. In Neuron, 112, 4048-4059.e7. doi:10.1016/j.neuron.2024.09.020. https://pubmed.ncbi.nlm.nih.gov/39419023/
3. Wei, L-J, Bai, D-M, Wang, Z-Y, Liu, B-C. . Upregulated lncRNA CACNA1G-AS1 aggravates the progression of colorectal cancer by downregulating p53. In European review for medical and pharmacological sciences, 24, 130-136. doi:10.26355/eurrev_202001_19902. https://pubmed.ncbi.nlm.nih.gov/31957825/
4. Yang, Jinghui, Li, Chunsheng, Li, Hang, E, Changyong. 2019. LncRNA CACNA1G-AS1 facilitates hepatocellular carcinoma progression through the miR-2392/C1orf61 pathway. In Journal of cellular physiology, 234, 18415-18422. doi:10.1002/jcp.28477. https://pubmed.ncbi.nlm.nih.gov/30908634/
5. Calhoun, Jeffrey D, Hawkins, Nicole A, Zachwieja, Nicole J, Kearney, Jennifer A. 2016. Cacna1g is a genetic modifier of epilepsy caused by mutation of voltage-gated sodium channel Scn2a. In Epilepsia, 57, e103-7. doi:10.1111/epi.13390. https://pubmed.ncbi.nlm.nih.gov/27112236/
6. Chemin, Jean, Siquier-Pernet, Karine, Nicouleau, Michaël, Lory, Philippe, Cantagrel, Vincent. . De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene. In Brain : a journal of neurology, 141, 1998-2013. doi:10.1093/brain/awy145. https://pubmed.ncbi.nlm.nih.gov/29878067/